- Home
- TOI vs DTIL Comparison
TOI vs DTIL Comparison
Compare TOI & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOI
- DTIL
- Stock Information
- Founded
- TOI 2007
- DTIL 2006
- Country
- TOI United States
- DTIL United States
- Employees
- TOI N/A
- DTIL N/A
- Industry
- TOI Medical/Nursing Services
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- TOI Health Care
- DTIL Health Care
- Exchange
- TOI Nasdaq
- DTIL Nasdaq
- Market Cap
- TOI 49.1M
- DTIL 43.3M
- IPO Year
- TOI N/A
- DTIL 2019
- Fundamental
- Price
- TOI $1.14
- DTIL $4.69
- Analyst Decision
- TOI
- DTIL Strong Buy
- Analyst Count
- TOI 0
- DTIL 3
- Target Price
- TOI N/A
- DTIL $37.67
- AVG Volume (30 Days)
- TOI 558.9K
- DTIL 134.3K
- Earning Date
- TOI 03-24-2025
- DTIL 03-26-2025
- Dividend Yield
- TOI N/A
- DTIL N/A
- EPS Growth
- TOI N/A
- DTIL N/A
- EPS
- TOI N/A
- DTIL 1.04
- Revenue
- TOI $393,412,000.00
- DTIL $68,696,000.00
- Revenue This Year
- TOI $23.95
- DTIL N/A
- Revenue Next Year
- TOI N/A
- DTIL $58.46
- P/E Ratio
- TOI N/A
- DTIL $4.59
- Revenue Growth
- TOI 21.33
- DTIL 40.98
- 52 Week Low
- TOI $0.13
- DTIL $3.61
- 52 Week High
- TOI $1.63
- DTIL $15.97
- Technical
- Relative Strength Index (RSI)
- TOI 64.39
- DTIL 39.70
- Support Level
- TOI $0.97
- DTIL $4.30
- Resistance Level
- TOI $1.34
- DTIL $5.72
- Average True Range (ATR)
- TOI 0.17
- DTIL 0.34
- MACD
- TOI 0.04
- DTIL -0.07
- Stochastic Oscillator
- TOI 63.83
- DTIL 23.81
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.